Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Japanese Global Strategy Update (3)
June 25, 2001
- Kraft: Record-high Operating, Ordinary Profits
June 18, 2001
- 10 Reported Products Including Diprivan Inj. Added to NHI Price List
June 18, 2001
- Kyowa Hakko Starts PII for KW-7158 in Europe
June 18, 2001
- 14 Active Ingredients Included in NHI Price List
June 18, 2001
- Takeda Discovers Metastasis Suppressor Peptide Ligand
June 18, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -1-
June 18, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIE -1-
June 18, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -2-
June 18, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
June 18, 2001
- Patient-Oriented Healthcare Discussed: JPMA Seminar
June 18, 2001
- REGULATORY NEWS IN BRIEF
June 18, 2001
- Taxol Approved for Gastric Cancer
June 18, 2001
- All Parties Should Cooperate to Establish Desirable Trade Practices: EAD Director
June 18, 2001
- DIAGNOSTIC NEWS IN BRIEF
June 18, 2001
- Drug Safety Measures by Korosho Must Meet Int'l Standards: PMSB
June 18, 2001
- FFITMA Reorganized
June 18, 2001
- Mefenamic Acid Should Not Be Used for Fevers Associated with Influenza: CDFS
June 18, 2001
- JEOL: New High Resolution Scanning Electron Microscope
June 18, 2001
- Matsumotokiyoshi Ties Up with Takada Yakkyoku
June 18, 2001
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…